• The Project
  • Meet Our Team
  • News
  • Contact
  • Suscribe to our Newsletter
  • 1st Newsletter

    1st Newsletter

    Oct 30, 2024

    —

    by

    antonio.combine
    in Newsletter

    Welcome to COMBINE-CT! We are excited to present our project. We are a consortium of clinical centres, research institutes, and healthcare companies, with the goal of bringing the CT scan to the forefront of the diagnosis, treatment planning, and follow-up of patients with coronary artery disease. In this newsletter, we will: Overview of the Project…

  • COMBINE-CT public-private partnership receives EUR 6.5 million Innovative Health Initiative grant to improve the diagnosis and treatment of patients with coronary artery disease

    COMBINE-CT public-private partnership receives EUR 6.5 million Innovative Health Initiative grant to improve the diagnosis and treatment of patients with coronary artery disease

    Apr 1, 2024

    —

    by

    antonio.combine
    in Press Releases

    The COMBINE-CT consortium [1], a Philips-coordinated public-private partnership, has received a EUR 6.5 million grant from the Innovative Health Initiative (IHI) to improve the diagnosis and treatment of patients with coronary artery disease. Coronary artery disease (CAD) is the build-up of fat and calcium (plaque) in the coronary arteries, gradually narrowing the arteries and obstructing…

COMBINE-CT

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101132862. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, EuropaBio, MedTech Europe and Vaccines Europe.

Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.

Privacy

  • Privacy Policy
  • Cookie Policy
  • Legal Notice

Social

  • Linkedin
  • Youtube
  • Twitter/X

Contact

  • Contact Us